Table of Contents

Optimization of a GCaMP Calcium Indicator for Neural Activity Imaging

  1. Loren L. Looger1
  1. 1Howard Hughes Medical Institute, Janelia Farm Research Campus, Ashburn, Virginia 20147,
  2. 2Champalimaud Neuroscience Programme, Champalimaud Centre for the Unknown, Doca de Pedrouços, 1400-038 Lisboa, Portugal,
  3. 3Medical Research Council Laboratory of Molecular Biology, Cambridge, CB2 0QH United Kingdom,
  4. 4Department of Chemistry, University of Puerto Rico–Río Piedras, San Juan, Puerto Rico 00931,
  5. 5Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut 06511,
  6. 6Department of Molecular Biology and Princeton Neuroscience Institute, Princeton University, Princeton, New Jersey 08544,
  7. 7Howard Hughes Medical Institute, Laboratory of Neural Circuits and Behavior, The Rockefeller University, New York, New York 10065,
  8. 8Department of Molecular and Cellular Biology, Center for Brain Science, Harvard University, Cambridge, Massachusetts 02138,
  9. 9Department of Physiology, Programs in Neuroscience, Genetics, and Developmental Biology, University of California, San Francisco, San Francisco, California 94158,
  10. 10National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bengaluru 560065, India, and
  11. 11Department of Physiology, University of California, Los Angeles, Los Angeles, California 90095
  1. Author contributions: J.A., B.S.K., H.B., L.L., S.S.-H.W., C.I.B., B.E.K., V.J., K.S., D.S.K., E.R.S., and L.L.L. designed research; J.A., T.-W.C., T.J.W., L.T., J.S.M., S.M., N.C.C., F.E., B.G.B., X.R.S., A.G., M.B.O., R.P., J.J.M., A.F., A.A., R.T., S.K., E.S., B.S.K., V.J., and D.S.K. performed research; F.E. and R.A.K. contributed unpublished reagents/analytic tools; J.A., T.-W.C., T.J.W., L.T., J.S.M., B.G.B., A.G., M.B.O., J.J.M., B.S.K., H.B., L.L., S.S.-H.W., C.I.B., B.E.K., V.J., K.S., D.S.K., E.R.S., and L.L.L. analyzed data; J.A., K.S., E.R.S., and L.L.L. wrote the paper.

  2. ↵*J.A. and T.-W.C. contributed equally to this work.

  • T. J. Wardill's present address: Marine Biology Laboratory, Woods Hole, MA 02543.

  • L. Tian's present address: Department of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Sacramento, CA 95817.

Abstract

Genetically encoded calcium indicators (GECIs) are powerful tools for systems neuroscience. Recent efforts in protein engineering have significantly increased the performance of GECIs. The state-of-the art single-wavelength GECI, GCaMP3, has been deployed in a number of model organisms and can reliably detect three or more action potentials in short bursts in several systems in vivo. Through protein structure determination, targeted mutagenesis, high-throughput screening, and a battery of in vitro assays, we have increased the dynamic range of GCaMP3 by severalfold, creating a family of “GCaMP5” sensors. We tested GCaMP5s in several systems: cultured neurons and astrocytes, mouse retina, and in vivo in Caenorhabditis chemosensory neurons, Drosophila larval neuromuscular junction and adult antennal lobe, zebrafish retina and tectum, and mouse visual cortex. Signal-to-noise ratio was improved by at least 2- to 3-fold. In the visual cortex, two GCaMP5 variants detected twice as many visual stimulus-responsive cells as GCaMP3. By combining in vivo imaging with electrophysiology we show that GCaMP5 fluorescence provides a more reliable measure of neuronal activity than its predecessor GCaMP3. GCaMP5 allows more sensitive detection of neural activity in vivo and may find widespread applications for cellular imaging in general.

  • Received May 30, 2012.
  • Revision received July 25, 2012.
  • Accepted August 1, 2012.

This article is freely available online through the J Neurosci Open Choice option.